Criteria for hazardous conditions requiring mandatory reporting
Within the framework of pharmacovigilance, a pharmaceutical worker bears professional responsibility for monitoring the safety of pharmacotherapy. There is a clear list of criteria upon which a side effect is classified as hazardous. Such conditions require mandatory official registration.
Conditions subject to strict recording include:
- Life threat: any side effects that pose an immediate danger to the patient's life at the time of their occurrence.
- Unexpected reactions: the development of adverse effects that have not been previously studied and are not described in the official instructions (package leaflet) of the medicinal product used.
- Severe consequences: adverse reactions whose severity led to the patient's temporary disability or required emergency or scheduled hospitalization.
- Clinical trials of new drugs: the occurrence of absolutely any, even minor, side effects when taking a new medicinal product if it is currently at the clinical trial stage.
Pharmacist's duties upon identifying hazardous reactions
If the patient's identified condition falls under the criteria of a hazardous one (life-threatening, undocumented, leading to hospitalization, or related to clinical trials), the pharmacist's algorithm of actions is strictly regulated. The specialist must perform the following steps:
- Provide emergency pre-medical care. The primary task of a pharmaceutical worker is to stabilize the patient's condition upon the development of an acute or life-threatening reaction right in the pharmacy organization.
- Document the case. After providing care, it is necessary to officially record the incident. To do this, the pharmacist is required to fill out the "Adverse Reaction Report Form" of a strictly established format.
- Notify responsible persons. Information about a severe or atypical side effect must be promptly transmitted to the pharmacy management as well as to the patient's attending physician who prescribed this drug.
Tactics for non-hazardous and known side effects
Not every adverse event requires emergency measures, filling out Report Forms, and notifying management.
If the developed side effect is assessed as non-hazardous, and its manifestations are already described in the instructions (package leaflet) for the medicinal product, the algorithm of actions is significantly simplified. In such situations, it is sufficient for the pharmacist to conduct competent counseling and strongly recommend that the patient consult their attending physician. The physician, in turn, will assess the condition and, if necessary, adjust the pharmacotherapy regimen or drug dosage.
Briefly: answers to topical questions
Which authority receives the completed adverse reaction report form?
The provided sources do not specify where the exact "Adverse Reaction Report Form" is sent. Roszdravnadzor is indicated as the recipient for the form "Notification of an adverse action, adverse reaction, or lack of expected therapeutic effect of a medicinal product".
The "PAD" rule for severe side effects: Provision of care (pre-medical), Alerting (management and physician), Documentation (fill out the Report Form).
Class and exam questions
Is it necessary to report all side effects of new drugs?
Yes, if a new medicinal product is at the clinical trial stage, absolutely any identified side effects must be reported, regardless of their severity.
What document must a pharmacist fill out in case of a hazardous reaction?
The pharmacist is obliged to document the case by filling out the "Adverse Reaction Report Form" of the established format.
Is it necessary to notify the physician in case of a life-threatening side effect?
Yes, the algorithm obliges the pharmacist to notify both the pharmacy management and the patient's attending physician upon identifying hazardous conditions.
What to do if the side effect is non-hazardous and described in the instructions?
In other cases (for non-hazardous and known reactions), it is sufficient for the pharmacist to recommend that the patient consult their attending physician.
What else to study on this topic
- Organization of the pharmacovigilance system in the Russian Federation
- Rules for providing first aid in a pharmacy
- Procedure for filling out the Adverse Reaction Report Form
- Differences between clinical trials and post-marketing surveillance
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on the topic "Pharmacist's action algorithm for side effects" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in "General Pharmacology"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.